| Market Capitalization (Millions $) |
190 |
| Shares
Outstanding (Millions) |
4 |
| Employees |
- |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
2 |
| Cash Flow (TTM) (Millions $) |
0 |
| Capital Exp. (TTM) (Millions $) |
0 |
Citius Oncology Inc
Tenx Keane Acquisition is a merger between Tenx Capital, a private equity firm, and Keane, a leading provider of comprehensive solutions for unclaimed property compliance and investigations. The acquisition aims to combine their respective expertise and resources to create a stronger entity in the unclaimed property industry.
Tenx Capital brings its financial expertise and capital resources to the partnership, while Keane brings its extensive experience and established presence in the field of unclaimed property compliance. Through this merger, the companies seek to expand their capabilities, enhance their service offerings, and create a larger market presence.
The acquisition is expected to drive growth for both parties by leveraging their synergies and expanding their customer base. It also offers an opportunity to develop innovative solutions and advanced technologies to better serve clients in managing and resolving unclaimed property obligations.
Overall, the Tenx Keane Acquisition aims to create a market leader in the unclaimed property industry by combining the strengths and capabilities of Tenx Capital and Keane.
Company Address: 420 Lexington Ave New York 10170 NY
Company Phone Number: 627-0058 Stock Exchange / Ticker: NASDAQ TENKU
|
